…the company announced that Roman Yelensky, Ph.D., executive vice president and chief technology officer, will be stepping down to co-found and lead a new startup in the cancer diagnostics space, working alongside a major healthcare investor.
This seems like an adequate explanation for the CTO’s departure.
p.s. Welcome back.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”